The dividend yield is computed based on the closing price of 30th April 2025. We have considered companies that have consistently paid dividend in the last 3 years – i.e FY24/CY23, FY23/CY22 and FY22/CY21.
Subscribe to Blog via Email
Join 539 other subscribers
Recent Posts
- Jubilant Pharmova has several triggers unfolding; maintain ‘BUY’ with TP of ₹1,385 (46% upside): Nuvama
- Ethos Ltd continues to deliver consistent growth; maintain BUY for target price of ₹4011 (45.1% upside): YES Securities
- Dollar Industries’ growth pillars are in place driven by project Lakshya. Buy for target price of ₹524 (30% upside): SMIFS
- Blue Jet Healthcare is ascending the value chain. Buy for target price of ₹865 (26% upside): Motilal Oswal
- Piramal Pharma’s long term prospects are intact. Buy for target price of ₹290 (38% upside): ICICI Direct
Recent Comments
- gokulram arunasalam on Axis Bank’s steep discount compared to private peers warrants re-rating. Buy for target price of ₹1350 (16% upside): ICICI Direct
- Jeffrey Borges on 16 Top Picks for January 2025 with up to 41% upside by Axis Securities
- anil on Ace Stock Picker Maheen Rahman Recommends Mega Multibagger Stocks Which Will Be “Next HDFC Bank, Kotak Bank”
- Shaileshbhai Rajwadi on Kenneth Andrade reveals his latest stock picks & strategy for 2024. He is very bullish about Pharma, Liquor and Metal stocks but is avoiding banking stocks
- Surineni Sudhakar on Sunil Singhania’s (Abakkus) purchase of 6.7% of Shriram Pistons appears to be because of its EV prospects
Leave a Reply